Thioredoxin interacting protein regulates age-associated neuroinflammation

Area of Science:

• Neuroscience
• Immunology
• Gerontology

Background:

• Aging-associated chronic inflammation (inflammaging) is linked to cognitive decline.
• NOD-like receptor pyrin domain containing-3 (NLRP3) inflammasome activation is a key mediator.
• Thioredoxin interacting protein (TXNIP) is crucial for NLRP3 inflammasome activity.

Purpose of the Study:

• To investigate the role of the TXNIP/NLRP3 inflammasome pathway in senile dementia.
• To explore TXNIP as a potential therapeutic target for age-related cognitive impairment.

Main Methods:

• Studies were conducted on sex-matched mice.
• TXNIP expression, NLRP3 inflammasome activation, and klotho levels were assessed in aged animals.
• TXNIP knockout and pharmacological inhibition were employed.
• Cognitive and sensorimotor functions were evaluated.

Main Results:

• TXNIP was upregulated in aged mice, correlating with NLRP3 inflammasome over-activity and IL-1β maturation.
• Klotho protein was depleted in aged males.
• TXNIP inhibition reversed NLRP3 hyperactivity, increased thioredoxin (TRX) levels, and upregulated FOXO-1 and mTOR.
• These molecular changes were associated with improved cognitive and sensorimotor abilities.

Conclusions:

• TXNIP plays a pivotal role in inflammaging and cognitive decline during aging.
• The TXNIP/NLRP3 inflammasome pathway is implicated in senile dementia.
• The thioredoxin system presents a potential therapeutic target for decelerating dementia.